Filtered By:
Source: Vaccine
Vaccination: Cervical Cancer Vaccine

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 213 results found since Jan 2013.

Bad news: The influence of news coverage and Google searches on Gardasil adverse event reporting.
CONCLUSION: The results suggest that some of the adverse events reported were not related to the vaccination itself, but to news coverage and internet search volumes, which may have contributed to public concerns about potentially unpleasant or harmful outcomes. These findings have implications for the importance of psychological and social factors in adverse event reporting, and the role of the news media in disseminating health information. PMID: 29128382 [PubMed - as supplied by publisher]
Source: Vaccine - November 8, 2017 Category: Allergy & Immunology Authors: Faasse K, Porsius JT, Faasse J, Martin LR Tags: Vaccine Source Type: research

Spontaneous reports of primary ovarian insufficiency after vaccination: A review of the vaccine adverse event reporting system (VAERS)
CONCLUSIONS: POI is rarely reported to VAERS. Most reports contained limited diagnostic information and were submitted after published cases of POI following HPV vaccination. Results of our review do not suggest a safety concern.PMID:36732165 | DOI:10.1016/j.vaccine.2022.12.038
Source: Vaccine - February 2, 2023 Category: Allergy & Immunology Authors: A Patricia Wodi Paige Marquez Adamma Mba-Jonas Faith Barash Kosal Nguon Pedro L Moro Source Type: research

Strategies for addressing vaccine hesitancy - A systematic review.
Abstract The purpose of this systematic review is to identify, describe and assess the potential effectiveness of strategies to respond to issues of vaccine hesitancy that have been implemented and evaluated across diverse global contexts. METHODS: A systematic review of peer reviewed (January 2007-October 2013) and grey literature (up to October 2013) was conducted using a broad search strategy, built to capture multiple dimensions of public trust, confidence and hesitancy concerning vaccines. This search strategy was applied and adapted across several databases and organizational websites. Descriptive analy...
Source: Vaccine - April 17, 2015 Category: Allergy & Immunology Authors: Jarrett C, Wilson R, O'Leary M, Eckersberger E, Larson HJ, SAGE Working Group on Vaccine Hesitancy Tags: Vaccine Source Type: research

Sex difference in the immunogenicity of the quadrivalent Human Papilloma Virus vaccine: Systematic review and meta-analysis
CONCLUSION: Females have higher antibody titers against HPV after receiving the qHPVV than do males. The difference is bigger in low-risk HPV strains. Adjusting the doses and schedules for each sex should be explored further.PMID:33637386 | DOI:10.1016/j.vaccine.2021.02.022
Source: Vaccine - February 27, 2021 Category: Allergy & Immunology Authors: Lafi Aldakak Vera Maria Huber Frank R ühli Nicole Bender Source Type: research

HPV vaccine acceptance in West Africa: A systematic literature review
Vaccine. 2021 Aug 5:S0264-410X(21)00835-5. doi: 10.1016/j.vaccine.2021.06.074. Online ahead of print.ABSTRACTHuman papillomavirus (HPV) infections are mostly sexually transmitted and cause the greatest share of infection-associated cancers. Each year more than half a million women are diagnosed with cervical cancer and the mortality rate in West Africa is over ten times higher than that of Northern Europe. HPV vaccines are highly effective at preventing various strains of the infection. However, vaccine hesitancy and access issues have led to low HPV vaccine acceptance in certain countries. A search strategy was developed ...
Source: Vaccine - August 9, 2021 Category: Allergy & Immunology Authors: Rose Wilson Source Type: research

Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects.
Abstract Prophylactic vaccines for human papillomavirus (HPV) are being introduced in many countries for the prevention of cervical cancer, the second most important cause of cancer-related death in women globally. This is likely to have a significant impact on the future burden of cervical cancer, particularly where screening is non-existent or limited in scale. Previous research on the challenges of vaccinating girls with the HPV vaccine has focused on evidence from developed countries. We conducted a systematic search of the literature in order to describe the barriers and challenges to implementation of HPV va...
Source: Vaccine - June 15, 2013 Category: Allergy & Immunology Authors: Wigle J, Coast E, Watson-Jones D Tags: Vaccine Source Type: research

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States-Do we need a broader vaccine policy?
CONCLUSIONS: With emerging evidence of the efficacy of the use of the HPV vaccine in preventing oral-HPV, more focus should be put on extending HPV vaccine to present oral HPV infection and oropharyngeal cancer. Also, implementing a broader HPV vaccine policy that include mandating HPV vaccines as a school-entry requirement for both sexes may increase vaccine use in the US for the greater good of the public. PMID: 24095883 [PubMed - as supplied by publisher]
Source: Vaccine - October 3, 2013 Category: Allergy & Immunology Authors: Osazuwa-Peters N Tags: Vaccine Source Type: research

A bibliometric analysis of systematic reviews on vaccines and immunisation.
CONCLUSIONS: SYSVAC provides a freely searchable platform to identify existing vaccine-policy-relevant systematic reviews. Systematic reviews will need to be assessed adequately for each specific question and quality. PMID: 29576305 [PubMed - as supplied by publisher]
Source: Vaccine - March 22, 2018 Category: Allergy & Immunology Authors: Fernandes S, Jit M, Bozzani F, Griffiths UK, Scott JAG, Burchett HED Tags: Vaccine Source Type: research

Therapeutic human papillomavirus vaccines in head and neck cancer: A systematic review of current clinical trials.
CONCLUSIONS: Treatment with therapeutic vaccines is a promising and seemingly safe strategy for patients with HPV+ head and neck cancer. However, there are not enough data to draw any further conclusions and clinical outcome measures and tumour responses to the vaccines are still missing. PMID: 30268734 [PubMed - as supplied by publisher]
Source: Vaccine - September 26, 2018 Category: Allergy & Immunology Authors: Schneider K, Grønhøj C, Hahn CH, von Buchwald C Tags: Vaccine Source Type: research

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials.
CONCLUSIONS: This review supports the premise that one HPV vaccine dose may be as effective in preventing HPV infection as multi-dose schedules in healthy young women. However, it also highlights the paucity of available evidence from purpose-designed, prospectively-randomised trials. Results from ongoing clinical trials assessing the efficacy and immunogenicity of single-dose HPV vaccination compared to currently-recommended schedules are awaited. PMID: 31870572 [PubMed - as supplied by publisher]
Source: Vaccine - December 19, 2019 Category: Allergy & Immunology Authors: Whitworth HS, Gallagher KE, Howard N, Mounier-Jack S, Mbwanji G, Kreimer AR, Basu P, Kelly H, Drolet M, Brisson M, Watson-Jones D Tags: Vaccine Source Type: research

Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis
Vaccine. 2021 Apr 6:S0264-410X(21)00428-X. doi: 10.1016/j.vaccine.2021.04.003. Online ahead of print.ABSTRACTThe coronavirus disease 2019 (COVID-19) pandemic has significantly affected utilization of preventative health care, including vaccines. We aimed to assess HPV vaccination rates during the pandemic, and conduct a simulation model-based analysis to estimate the impact of current coverage and future pandemic recovery scenarios on disease outcomes. The model population included females and males of all ages in the US. The model compares pre-COVID vaccine uptake to 3 reduced coverage scenarios with varying recovery spee...
Source: Vaccine - April 20, 2021 Category: Allergy & Immunology Authors: Vincent Daniels Kunal Saxena Craig Roberts Smita Kothari Shelby Corman Lixia Yao Linda Niccolai Source Type: research